[go: up one dir, main page]

IL104941A - Indole derivatives and pharmaceutical compositions containing them - Google Patents

Indole derivatives and pharmaceutical compositions containing them

Info

Publication number
IL104941A
IL104941A IL104941A IL10494193A IL104941A IL 104941 A IL104941 A IL 104941A IL 104941 A IL104941 A IL 104941A IL 10494193 A IL10494193 A IL 10494193A IL 104941 A IL104941 A IL 104941A
Authority
IL
Israel
Prior art keywords
compound
formula
ylmethyl
compounds
benzyl
Prior art date
Application number
IL104941A
Other languages
English (en)
Other versions
IL104941A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IL11891093A priority Critical patent/IL118910A/en
Priority to IL11891193A priority patent/IL118911A/xx
Publication of IL104941A0 publication Critical patent/IL104941A0/xx
Publication of IL104941A publication Critical patent/IL104941A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL104941A 1992-03-05 1993-03-04 Indole derivatives and pharmaceutical compositions containing them IL104941A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL11891093A IL118910A (en) 1992-03-05 1993-03-04 Intermediates for the synthesis of indole derivatives
IL11891193A IL118911A (en) 1992-03-05 1993-03-04 Intermediates for the synthesis of indole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84664092A 1992-03-05 1992-03-05

Publications (2)

Publication Number Publication Date
IL104941A0 IL104941A0 (en) 1993-07-08
IL104941A true IL104941A (en) 1998-06-15

Family

ID=25298499

Family Applications (1)

Application Number Title Priority Date Filing Date
IL104941A IL104941A (en) 1992-03-05 1993-03-04 Indole derivatives and pharmaceutical compositions containing them

Country Status (30)

Country Link
US (2) US5594014A (xx)
EP (1) EP0629199B1 (xx)
JP (1) JPH07121943B2 (xx)
KR (1) KR0179073B1 (xx)
CN (4) CN1032309C (xx)
AT (1) ATE218566T1 (xx)
AU (1) AU666716B2 (xx)
BR (1) BR9306012A (xx)
CA (1) CA2117643C (xx)
CZ (1) CZ282652B6 (xx)
DE (1) DE69331988T2 (xx)
DK (1) DK0629199T3 (xx)
EG (1) EG20416A (xx)
ES (1) ES2176199T3 (xx)
FI (1) FI930968A (xx)
HU (1) HU219489B (xx)
IL (1) IL104941A (xx)
MX (1) MX9301197A (xx)
MY (1) MY109298A (xx)
NO (1) NO302617B1 (xx)
NZ (1) NZ249755A (xx)
PL (1) PL172388B1 (xx)
PT (1) PT629199E (xx)
RU (1) RU2124012C1 (xx)
SK (1) SK281938B6 (xx)
TW (1) TW288010B (xx)
UA (1) UA39866C2 (xx)
WO (1) WO1993018032A1 (xx)
YU (1) YU14893A (xx)
ZA (1) ZA931539B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
CA2133413C (en) 1992-04-07 2001-04-10 John Eugene Macor Indole derivatives as 5-ht1 antagonists
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
CZ59996A3 (en) * 1993-08-31 1996-06-12 Pfizer 5-arylindole derivatives per se and for treating diseases, intermediates for their preparation and pharmaceutical compositions based thereon
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420503D0 (en) * 1994-10-11 1994-11-23 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
IL124436A0 (en) * 1995-12-29 1998-12-06 Boehringer Ingelheim Phaarmace Phenyl thiazole derivatives with anti herpes virus properties
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
EE200300246A (et) 2000-11-27 2003-10-15 Pfizer Products Inc. EP4 retseptori suhtes selektiivsed agonistid osteoporoosi raviks
JP2004526781A (ja) * 2001-04-20 2004-09-02 ワイス 5−ヒドロキシトリプトアミン−6リガンドとしてのヘテロシクリルアルコキシ−、−アルキルチオ−および−アルキルアミノベンザゾール誘導体
ITRM20020255A1 (it) * 2002-05-09 2003-11-10 Polifarma Spa Tautomero enolico dell'acido 3-indolilpiruvico, suoi sali e usi terapeutici.
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
MX2022009528A (es) * 2020-02-04 2022-11-14 Mindset Pharma Inc Derivados de 3-pirrolidina-indol como agentes psicodélicos serotoninérgicos para el tratamiento de trastornos del snc.
PL243119B1 (pl) * 2020-04-16 2023-06-26 Univ Jagiellonski Rozpuszczalne w wodzie modyfikowane pochodne aminokwasowe nadające się do leczenia chorób o podłożu neurologicznym oraz zaburzeń psychiatrycznych

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
BE889931A (fr) * 1980-08-12 1982-02-11 Glaxo Group Ltd Derives indoliques, leur preparation et leurs applications en tant que medicaments
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
IL114690A (en) * 1990-06-07 1997-02-18 Wellcome Found Antimigraine oxazolidinone substituted indole derivatives
JP2575272B2 (ja) * 1990-10-15 1997-01-22 フアイザー・インコーポレイテツド インドール誘導体
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
TW263508B (xx) * 1991-02-12 1995-11-21 Pfizer

Also Published As

Publication number Publication date
DE69331988D1 (de) 2002-07-11
NO943261D0 (no) 1994-09-02
ATE218566T1 (de) 2002-06-15
CN1032309C (zh) 1996-07-17
CN1136566A (zh) 1996-11-27
CN1082044A (zh) 1994-02-16
ES2176199T3 (es) 2002-12-01
HU9300593D0 (en) 1993-05-28
HUT64061A (en) 1993-11-29
PT629199E (pt) 2002-09-30
TW288010B (xx) 1996-10-11
AU666716B2 (en) 1996-02-22
CN1136432A (zh) 1996-11-27
SK105294A3 (en) 1995-05-10
IL104941A0 (en) 1993-07-08
UA39866C2 (uk) 2001-07-16
PL172388B1 (pl) 1997-09-30
CZ282652B6 (cs) 1997-08-13
RU94040914A (ru) 1996-08-10
FI930968A0 (fi) 1993-03-04
YU14893A (sh) 1996-05-20
SK281938B6 (sk) 2001-09-11
FI930968A (fi) 1993-09-06
AU3733093A (en) 1993-10-05
US5594014A (en) 1997-01-14
CN1044910C (zh) 1999-09-01
ZA931539B (en) 1994-09-05
BR9306012A (pt) 1997-11-18
NO943261L (no) 1994-09-02
NZ249755A (en) 1996-08-27
CA2117643A1 (en) 1993-09-16
EP0629199B1 (en) 2002-06-05
CN1082815C (zh) 2002-04-17
JPH07500353A (ja) 1995-01-12
MX9301197A (es) 1993-09-01
KR950700291A (ko) 1995-01-16
CA2117643C (en) 2000-03-14
NO302617B1 (no) 1998-03-30
EP0629199A1 (en) 1994-12-21
WO1993018032A1 (en) 1993-09-16
CN1044909C (zh) 1999-09-01
CZ212594A3 (en) 1995-06-14
DK0629199T3 (da) 2002-07-15
US5717102A (en) 1998-02-10
DE69331988T2 (de) 2002-09-19
RU2124012C1 (ru) 1998-12-27
MY109298A (en) 1996-12-31
JPH07121943B2 (ja) 1995-12-25
KR0179073B1 (ko) 1999-03-20
HU219489B (hu) 2001-04-28
CN1136565A (zh) 1996-11-27
EG20416A (en) 1999-02-28

Similar Documents

Publication Publication Date Title
US6387937B1 (en) Indole derivatives
CA2117643C (en) Indole derivatives
US20080090797A1 (en) {Beta}-Lactamyl vasopression V1a antagonists and methods of use
EP0635015B1 (en) Acylaminoindole derivatives as 5-ht1 agonists
NZ267487A (en) 5-arylindole derivatives and pharmaceutical compositions thereof
AP632A (en) Therapeutic heterocyclic compounds.
IL118910A (en) Intermediates for the synthesis of indole derivatives
US6380233B1 (en) Indole derivatives as 5-HT1 agonists
IL121326A (en) N-substituted pyrolidin-2-yl methyl indole derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees